Showing results (11-20 of 171) with videos related to
Sort By:
Pageof 18
Expert Review of Anticancer Therapy|December 3, 2008
Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junctionGeoffrey Y Ku, David H IlsonCurrent Opinion in Gastroenterology|September 9, 2014
Management of gastric cancerGeoffrey Y Ku, David H IlsonJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2009
Successful treatment of esophageal cancer with airway invasion with induction chemotherapy and concurrent chemoradiotherapyGeoffrey Y Ku, Karyn A Goodman, Valerie W Rusch, et al.American Journal of Clinical Oncology|December 6, 2012
Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancerYelena Y Janjigian, Geoffrey Y Ku, Jenny C Campbell, et al.Cancer Investigation|February 17, 2009
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumorsGeoffrey Y Ku, Eileen M O'Reilly, Leonard B Saltz, et al.Cancer Chemotherapy and Pharmacology|February 14, 2008
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancerGeoffrey Y Ku, David H Ilson, Lawrence H Schwartz, et al.Surgical Oncology Clinics of North America|March 11, 2017
The Current Status of Immunotherapies in Esophagogastric CancerGeoffrey Y KuHematology/Oncology Clinics of North America|March 6, 2019
The Current Status of Immunotherapies in Esophagogastric CancerGeoffrey Y KuTranslational Gastroenterology and Hepatology|October 19, 2020
Next generation sequencing in gastric or gastroesophageal adenocarcinomaGeoffrey Y KuChinese Clinical Oncology|November 14, 2017
Systemic therapy for esophageal cancer: chemotherapyGeoffrey Y KuPageof 18